Showing results (1561-1570 of 2,693) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|May 27, 2006
New world cutaneous leishmaniasis in travellersEli Schwartz, Cristoph Hatz, Johannes Blum
The Lancet. Infectious Diseases|May 27, 2006
Interactions between HIV infection and leprosy: a paradoxAndrew P Ustianowski, Stephen D Lawn, Diana N J Lockwood
The Lancet. Infectious Diseases|May 27, 2006
Oral cholera vaccines: use in clinical practiceDavid R Hill, Lisa Ford, David G Lalloo
The Lancet. Infectious Diseases|September 30, 2006
Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic reviewKaren R Steingart, Vivienne Ng, Megan Henry, et al.
The Lancet. Infectious Diseases|April 28, 2005
Management of anthrax meningitisJames J Sejvar, Fred C Tenover, David S Stephens
The Lancet. Infectious Diseases|December 2, 2022
Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trialVictor Kande Betu Kumeso, Wilfried Mutombo Kalonji, Sandra Rembry, et al.
The Lancet. Infectious Diseases|November 27, 2022
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control studyAnnabel A Powell, Freja Kirsebom, Julia Stowe, et al.
The Lancet. Infectious Diseases|December 16, 2022
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trialEphraim L Tsalik, Nadine G Rouphael, Ruxana T Sadikot, et al.
The Lancet. Infectious Diseases|December 19, 2022
Human rabies despite post-exposure prophylaxis: a systematic review of fatal breakthrough infections after zoonotic exposuresErin R Whitehouse, Anna Mandra, Jesse Bonwitt, et al.
The Lancet. Infectious Diseases|December 12, 2022
TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trialMan-Fung Yuen, Rozalina Balabanska, Emmanuelle Cottreel, et al.
Pageof 270